Table 2 Description of the values related to hospitalizations for immunopreventable diseases researched in Brazil, broken down by disease and age group (from 20 to 59 years), in the period from 2008 to 2018
From: Hospital costs of immunopreventable diseases in the economically active population in Brazil
Immunopreventable Disease | Ages | |||
|---|---|---|---|---|
20–29 years | 30–39 years | 40–49 years | 50–59 years | |
Mumps | R$ 100,485.28 | R$ 58,824.95 | R$ 51,841.86 | R$ 34,766.63 |
Whooping cough | R$ 65,585.32 | R$ 58,387.86 | R$ 94,306.22 | R$ 93,301.75 |
Diphtheria | R$ 190,802.84 | R$ 189,147.44 | R$ 216,846.83 | R$ 384,056.01 |
Yellow fever | R$ 642,186.04 | R$ 423,175.01 | R$ 570,689.54 | R$ 493,713.30 |
Influenza | R$ 16,515,703.89 | R$ 14,921,731.37 | R$ 15,713,988.13 | R$ 18,265,972.35 |
Hepatitis B | R$ 719,203.29 | R$ 1,729,574.63 | R$ 2,495,070.43 | R$ 2,869,201.02 |
Meningococcal disease | R$ 4,425,265.05 | R$ 4,192,447.05 | R$ 3,951,200.20 | R$ 3,395,157.39 |
Rubella / German measles | R$ 6131.60 | R$ 2832.55 | R$ 1295.10 | R$ 1664.22 |
Measles | R$ 33,344.13 | R$ 25,596.52 | R$ 13,027.31 | R$ 14,008.51 |
Neonatal and accidental tetanus | R$ 614,935.46 | R$ 1,318,430.67 | R$ 2,052,156.93 | R$ 2,800,066.40 |
Chickenpox/Herpes Zoster | R$ 2,880,801.00 | R$ 3,221,943.80 | R$ 3,957,090.72 | R$ 5,876,140.94 |
TOTAL | R$ 26,194,443.90 | R$ 26,142,091.85 | R$ 29,117,513.27 | R$ 34,228,048.52 |